Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 13/20 | 0.40 |
| ▸ | CTNNB1 | P35222 | 13/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 5/20 | 0.39 |
| ▸ | DRD3 | P35462 | 5/20 | 0.39 |
| ▸ | DRD1 | P21728 | 2/20 | 0.39 |
| ▸ | DRD4 | P21917 | 2/20 | 0.39 |
| ▸ | DRD5 | P21918 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29319831 | 0.83 | BCL9 (0.45) | BCL9CTNNB1PPARA | |
| SCHEMBL29319933 | 0.82 | BCL9 (0.44) | BCL9CTNNB1PPARADRD2DRD3 | |
| SCHEMBL29320186 | 0.82 | BCL9 (0.39) | BCL9CTNNB1PPARADRD2DRD3 | |
| SCHEMBL29319187 | 0.81 | BCL9 (0.40) | BCL9CTNNB1PPARADRD2DRD3 | |
| SCHEMBL29320072 | 0.80 | BCL9 (0.40) | BCL9CTNNB1PPARADRD2DRD3 | |
| SCHEMBL29320162 | 0.80 | BCL9 (0.42) | BCL9CTNNB1PPARA | |
| SCHEMBL29320096 | 0.77 | BCL9 (0.45) | BCL9CTNNB1PPARA | |
| SCHEMBL29319218 | 0.76 | BCL9 (0.39) | BCL9CTNNB1DRD2DRD3DRD1 | |
| SCHEMBL29320207 | 0.76 | BCL9 (0.44) | BCL9CTNNB1PPARA | |
| SCHEMBL29319057 | 0.74 | BCL9 (0.38) | BCL9CTNNB1DRD2DRD3DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024145931-A1 | SMALL MOLECULE INHIBITOR FOR β-CATENIN/BCL9 PROTEIN-PROTEIN INTERACTION AND USE THEREOF | 上海医药工业研究院有限公司 | 2024-07-11 | — | — | WO | disclosed |